- Pick PlasmaBlade for precise dissection with less heat and less surgical smoke.
- Pick Aquamantys when the problem is oozing tissue or bone that needs sealing.
- Pick both when a case needs cutting and sealing, since one AEX generator powers each.
- Treat blood loss claims with care, because independent studies disagree.
Neither one wins outright. In the AquaMantys vs PlasmaBlade debate, the winner depends on the job. PlasmaBlade cuts soft tissue with less heat, and Aquamantys seals bleeding tissue and bone.
Both are Medtronic devices, and one generator can run them together. So the 2026 question is less "which one?" and more "which one first, and when do you need both?"
How we checked the claims
Surgical device marketing loves big percentages. So every figure below carries a label that tells you where it came from.
- Manufacturer data: Medtronic product pages and brochures.
- Regulatory records: FDA 510(k) clearance listings.
- Independent evidence: peer-reviewed trials, meta-analyses and a CADTH review.
This article is general information, not medical advice. Surgeons and hospital committees choose tools case by case.
What each tool actually does
Aquamantys uses a method Medtronic calls Transcollation. It combines RF energy and saline to seal soft tissue and bone. Medtronic says the heat shrinks collagen and may close vessels under 1 mm.
PlasmaBlade sends short RF pulses along a thin electrode with 99.5% insulation. It cuts and coagulates soft tissue. Medtronic markets it as offering the precision of a scalpel with the bleeding control of traditional electrosurgery.
| Feature | Aquamantys bipolar sealer | PlasmaBlade X dissector |
|---|---|---|
| Main job | Hemostatic sealing of soft tissue and bone | Cutting and coagulating soft tissue |
| Energy method | RF energy plus saline | Brief RF pulses on an insulated electrode |
| Operating temperature | About 100°C | 40 to 170°C |
| Smoke | Nearly negligible in a benchtop test | 95% less in cut mode, 84% less in coag mode |
| Listed specialties | Orthopaedics, spine, oncology, neurosurgery, thoracic, cardiac implantable devices | Breast, ENT, orthopaedic, spinal, neurological, general surgery |
| Generator | AEX | AEX |
Heat: the number behind most claims
Medtronic reports that PlasmaBlade X runs at 40 to 170°C. It lists traditional electrosurgery at 200 to 350°C. Aquamantys sits near 100°C, which Medtronic calls nearly 200°C below traditional devices.
Cooler is not always better. Sealing a vessel needs enough heat to shrink collagen, and Medtronic ties Aquamantys to about 100°C for that reason.
Brochures love the word "less": less heat, less smoke, less damage. Surgeons would also like more evidence.
Where PlasmaBlade has the edge
- Surgical smoke: a Medtronic benchtop study (n=6) found 95% less smoke in cut mode and 84% less in coag mode (p=.01).
- Thermal injury: Medtronic reports 74% less thermal injury depth after skin incision.
- Visibility tools: the X 3.0S LIGHT model adds integrated smoke evacuation and four LEDs.
- Cardiac device surgery: a Medtronic brochure cites 40% shorter cath lab time and $155 saved per case.
Independent evidence is thinner. A CADTH review found limited and mixed results. Some studies showed shorter wound healing and drain time with PlasmaBlade. Others showed no difference in procedure time or infection.
CADTH also flagged low methodological quality and found no cost-effectiveness evidence. A randomized trial in abdominoplasty found no significant seroma difference. A 40-patient breast reconstruction trial saw more seroma with electrocautery at days 7, 14 and 42, but not by a significant margin.
Where Aquamantys has the edge
Aquamantys targets bleeding, and the data here is larger but contested.
- Pooled randomized trials (2018): a meta-analysis in major orthopedic surgery found about 105 mL less intraoperative blood loss and a transfusion risk ratio of 0.68, with no extra infections.
- Primary knee replacement (2019): a separate meta-analysis found no evidence to support routine use.
- Prospective cohort (2020): a Level II study found no difference in day-3 blood loss (1,240 vs 1,376 mL).
- Bilateral knee replacement (2014): patients were 35% less likely to need transfusion, but operative time rose.
The strongest numbers come from Medtronic itself. Its spine brochure reports the following for multi-level fusion.
Does the extra cost pay off?
That depends on the case and the hospital. The 2014 bilateral knee study found the transfusion savings did not exceed the per-case device cost. Medtronic, by contrast, cites average savings of $745 per spine procedure, using 2013 blood acquisition costs.
We found no public price list for either device. Ask your vendor for current pricing, then compare it with your own transfusion and operating room data.
Which tool fits which job
| Situation | Lean toward | Evidence basis |
|---|---|---|
| Multi-level spine fusion with heavy bleeding | Aquamantys | Manufacturer data plus pooled orthopedic trials |
| Skin and soft tissue dissection | PlasmaBlade | Manufacturer data, mixed independent results |
| Breast surgery dissection | PlasmaBlade | Small trials, results not conclusive |
| Primary knee replacement | Neither by default | Meta-analysis found no routine-use benefit |
| Cardiac device pocket | PlasmaBlade | Medtronic data; CADTH noted less lead damage |
| Case needs cutting and sealing | Both | Shared AEX generator |
The twist: one generator runs both
Medtronic says the AEX generator powers all Aquamantys and PlasmaBlade devices. It also allows both technologies to fire at once. That makes the choice less binary than the headline suggests.
The regulatory trail backs this up. The FDA cleared the AEX generator with PlasmaBlade T on December 31, 2014 (K143175). The PlasmaBlade T handpiece uses RF energy with saline for a broader coagulative effect, similar to Aquamantys.
Later, the FDA cleared PlasmaBlade X 3.0S and 4.0 in August 2018 (K181257). Clearance means the devices are cleared for use. It does not prove they beat a rival.
What the evidence still cannot tell you
- We did not find a published head-to-head trial of the two devices.
- The smoke data comes from a six-sample bench test.
- The biggest blood loss gains come from manufacturer materials.
- Independent knee studies conflict with spine and pooled orthopedic findings.
- CADTH found no cost-effectiveness data for PlasmaBlade.
So the honest 2026 answer is a procedure-by-procedure one. Ask each department what it needs to cut, what it needs to seal, and what its own numbers show.
FAQ
Is PlasmaBlade better than Aquamantys?
Neither is better overall. PlasmaBlade is built for cutting soft tissue at lower temperatures. Aquamantys is built for sealing bleeding tissue and bone.
Do Aquamantys and PlasmaBlade use the same generator?
Yes. Medtronic says the AEX generator powers both families and supports simultaneous activation.
Does Aquamantys reduce blood loss?
Results are mixed. Pooled trials in major orthopedic surgery showed less blood loss, but a primary knee replacement meta-analysis did not support routine use.
How much less smoke does PlasmaBlade make?
Medtronic's benchtop study found 95% less in cut mode and 84% less in coag mode. That was six samples on a bench, so patient results may differ.
Sources
- Medtronic: Aquamantys bipolar sealers
- Medtronic: Aquamantys system and Transcollation
- Medtronic: PlasmaBlade X dissection device
- Medtronic: PEAK PlasmaBlade device models
- Medtronic: surgical smoke benchtop study summary (PDF)
- Medtronic spine brochure: blood loss and transfusion figures
- Medtronic: AEX generator value summary (PDF)
- Medtronic: cardiac implantable device solutions brochure (PDF)
- FDA 510(k) K143175: AEx Generator and PlasmaBlade T
- FDA 510(k) K170610: PlasmaBlade T summary
- Medtronic Advanced Energy FDA clearance list (K181257)
- CADTH: PEAK PlasmaBlade vs traditional electrocautery review
- Oncotarget (2018): bipolar sealer meta-analysis in major orthopedic surgery
- Medicine (2019): bipolar sealer vs electrocautery in primary knee replacement
- Journal of Knee Surgery (2020): bipolar sealers and primary knee replacement
- Saline-coupled bipolar sealing in simultaneous bilateral knee replacement (2014)
- Randomized trial: plasmakinetic cautery in abdominal flap breast reconstruction
Keep reading
Choosing medical supplies is rarely about one number. Our guide to Kerlix vs Kling bandage rolls applies the same match-the-tool-to-the-task logic.
- Pick PlasmaBlade for precise dissection with less heat and less surgical smoke.
- Pick Aquamantys when the problem is oozing tissue or bone that needs sealing.
- Pick both when a case needs cutting and sealing, since one AEX generator powers each.
- Treat blood loss claims with care, because independent studies disagree.
Neither one wins outright. In the AquaMantys vs PlasmaBlade debate, the winner depends on the job. PlasmaBlade cuts soft tissue with less heat, and Aquamantys seals bleeding tissue and bone.
Both are Medtronic devices, and one generator can run them together. So the 2026 question is less "which one?" and more "which one first, and when do you need both?"
How we checked the claims
Surgical device marketing loves big percentages. So every figure below carries a label that tells you where it came from.
- Manufacturer data: Medtronic product pages and brochures.
- Regulatory records: FDA 510(k) clearance listings.
- Independent evidence: peer-reviewed trials, meta-analyses and a CADTH review.
This article is general information, not medical advice. Surgeons and hospital committees choose tools case by case.
What each tool actually does
Aquamantys uses a method Medtronic calls Transcollation. It combines RF energy and saline to seal soft tissue and bone. Medtronic says the heat shrinks collagen and may close vessels under 1 mm.
PlasmaBlade sends short RF pulses along a thin electrode with 99.5% insulation. It cuts and coagulates soft tissue. Medtronic markets it as offering the precision of a scalpel with the bleeding control of traditional electrosurgery.
| Feature | Aquamantys bipolar sealer | PlasmaBlade X dissector |
|---|---|---|
| Main job | Hemostatic sealing of soft tissue and bone | Cutting and coagulating soft tissue |
| Energy method | RF energy plus saline | Brief RF pulses on an insulated electrode |
| Operating temperature | About 100°C | 40 to 170°C |
| Smoke | Nearly negligible in a benchtop test | 95% less in cut mode, 84% less in coag mode |
| Listed specialties | Orthopaedics, spine, oncology, neurosurgery, thoracic, cardiac implantable devices | Breast, ENT, orthopaedic, spinal, neurological, general surgery |
| Generator | AEX | AEX |
Heat: the number behind most claims
Medtronic reports that PlasmaBlade X runs at 40 to 170°C. It lists traditional electrosurgery at 200 to 350°C. Aquamantys sits near 100°C, which Medtronic calls nearly 200°C below traditional devices.
Cooler is not always better. Sealing a vessel needs enough heat to shrink collagen, and Medtronic ties Aquamantys to about 100°C for that reason.
Brochures love the word "less": less heat, less smoke, less damage. Surgeons would also like more evidence.
Where PlasmaBlade has the edge
- Surgical smoke: a Medtronic benchtop study (n=6) found 95% less smoke in cut mode and 84% less in coag mode (p=.01).
- Thermal injury: Medtronic reports 74% less thermal injury depth after skin incision.
- Visibility tools: the X 3.0S LIGHT model adds integrated smoke evacuation and four LEDs.
- Cardiac device surgery: a Medtronic brochure cites 40% shorter cath lab time and $155 saved per case.
Independent evidence is thinner. A CADTH review found limited and mixed results. Some studies showed shorter wound healing and drain time with PlasmaBlade. Others showed no difference in procedure time or infection.
CADTH also flagged low methodological quality and found no cost-effectiveness evidence. A randomized trial in abdominoplasty found no significant seroma difference. A 40-patient breast reconstruction trial saw more seroma with electrocautery at days 7, 14 and 42, but not by a significant margin.
Where Aquamantys has the edge
Aquamantys targets bleeding, and the data here is larger but contested.
- Pooled randomized trials (2018): a meta-analysis in major orthopedic surgery found about 105 mL less intraoperative blood loss and a transfusion risk ratio of 0.68, with no extra infections.
- Primary knee replacement (2019): a separate meta-analysis found no evidence to support routine use.
- Prospective cohort (2020): a Level II study found no difference in day-3 blood loss (1,240 vs 1,376 mL).
- Bilateral knee replacement (2014): patients were 35% less likely to need transfusion, but operative time rose.
The strongest numbers come from Medtronic itself. Its spine brochure reports the following for multi-level fusion.
Does the extra cost pay off?
That depends on the case and the hospital. The 2014 bilateral knee study found the transfusion savings did not exceed the per-case device cost. Medtronic, by contrast, cites average savings of $745 per spine procedure, using 2013 blood acquisition costs.
We found no public price list for either device. Ask your vendor for current pricing, then compare it with your own transfusion and operating room data.
Which tool fits which job
| Situation | Lean toward | Evidence basis |
|---|---|---|
| Multi-level spine fusion with heavy bleeding | Aquamantys | Manufacturer data plus pooled orthopedic trials |
| Skin and soft tissue dissection | PlasmaBlade | Manufacturer data, mixed independent results |
| Breast surgery dissection | PlasmaBlade | Small trials, results not conclusive |
| Primary knee replacement | Neither by default | Meta-analysis found no routine-use benefit |
| Cardiac device pocket | PlasmaBlade | Medtronic data; CADTH noted less lead damage |
| Case needs cutting and sealing | Both | Shared AEX generator |
The twist: one generator runs both
Medtronic says the AEX generator powers all Aquamantys and PlasmaBlade devices. It also allows both technologies to fire at once. That makes the choice less binary than the headline suggests.
The regulatory trail backs this up. The FDA cleared the AEX generator with PlasmaBlade T on December 31, 2014 (K143175). The PlasmaBlade T handpiece uses RF energy with saline for a broader coagulative effect, similar to Aquamantys.
Later, the FDA cleared PlasmaBlade X 3.0S and 4.0 in August 2018 (K181257). Clearance means the devices are cleared for use. It does not prove they beat a rival.
What the evidence still cannot tell you
- We did not find a published head-to-head trial of the two devices.
- The smoke data comes from a six-sample bench test.
- The biggest blood loss gains come from manufacturer materials.
- Independent knee studies conflict with spine and pooled orthopedic findings.
- CADTH found no cost-effectiveness data for PlasmaBlade.
So the honest 2026 answer is a procedure-by-procedure one. Ask each department what it needs to cut, what it needs to seal, and what its own numbers show.
FAQ
Is PlasmaBlade better than Aquamantys?
Neither is better overall. PlasmaBlade is built for cutting soft tissue at lower temperatures. Aquamantys is built for sealing bleeding tissue and bone.
Do Aquamantys and PlasmaBlade use the same generator?
Yes. Medtronic says the AEX generator powers both families and supports simultaneous activation.
Does Aquamantys reduce blood loss?
Results are mixed. Pooled trials in major orthopedic surgery showed less blood loss, but a primary knee replacement meta-analysis did not support routine use.
How much less smoke does PlasmaBlade make?
Medtronic's benchtop study found 95% less in cut mode and 84% less in coag mode. That was six samples on a bench, so patient results may differ.
Sources
- Medtronic: Aquamantys bipolar sealers
- Medtronic: Aquamantys system and Transcollation
- Medtronic: PlasmaBlade X dissection device
- Medtronic: PEAK PlasmaBlade device models
- Medtronic: surgical smoke benchtop study summary (PDF)
- Medtronic spine brochure: blood loss and transfusion figures
- Medtronic: AEX generator value summary (PDF)
- Medtronic: cardiac implantable device solutions brochure (PDF)
- FDA 510(k) K143175: AEx Generator and PlasmaBlade T
- FDA 510(k) K170610: PlasmaBlade T summary
- Medtronic Advanced Energy FDA clearance list (K181257)
- CADTH: PEAK PlasmaBlade vs traditional electrocautery review
- Oncotarget (2018): bipolar sealer meta-analysis in major orthopedic surgery
- Medicine (2019): bipolar sealer vs electrocautery in primary knee replacement
- Journal of Knee Surgery (2020): bipolar sealers and primary knee replacement
- Saline-coupled bipolar sealing in simultaneous bilateral knee replacement (2014)
- Randomized trial: plasmakinetic cautery in abdominal flap breast reconstruction
Keep reading
Choosing medical supplies is rarely about one number. Our guide to Kerlix vs Kling bandage rolls applies the same match-the-tool-to-the-task logic.
